13.25

0.49% 0.065

After Hours: 13.25

Jade Biosciences Inc (JBIO)

Overview News Price History Discussions Forecast

Jade Biosciences Inc stock is traded at $13.25, with a volume of 207.61K. It is up +0.49% in the last 24 hours and down -1.71% over the past month. Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

Previous Close:

$13.19

Open:

$13.05

24h Volume:

207.61K

Relative Volume:

0.71

Market Cap:

$653.41M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-14.13%

1M Performance:

-1.71%

6M Performance:

+26.43%

1Y Performance:

+0.00%

1-Day Range:

$12.80

$13.54

1-Week Range:

$12.52

$15.93

52-Week Range:

$6.565

$17.71

Jade Biosciences Inc Stock (JBIO) Company Profile

Name

Jade Biosciences Inc

Sector

Healthcare (1114)

Industry

Biotechnology (621)

Phone

(781) 312-3013

Address

221 CRESCENT ST., WALTHAM

Employee

Twitter

Next Earnings Date

2025-05-19

Latest SEC Filings

JBIO's Discussions on Twitter

Compare JBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JBIO Jade Biosciences Inc	13.25	650.21M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	469.68	122.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	801.01	85.37B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	399.40	55.82B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	795.57	50.67B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	170.27	37.54B	447.02M	-1.18B	-906.14M	-6.1812

Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-09-25	Initiated	BTIG Research	Buy
Jul-14-25	Initiated	Jefferies	Buy
Jun-16-25	Upgrade	Guggenheim	Neutral → Buy
May-07-25	Initiated	Wedbush	Outperform
May-05-25	Initiated	Stifel	Buy
May-02-25	Initiated	TD Cowen	Buy
Jun-18-24	Downgrade	Evercore ISI	Outperform → In-line
Jun-18-24	Downgrade	TD Cowen	Buy → Hold
Jun-18-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Jun-17-24	Downgrade	Guggenheim	Buy → Neutral
Jun-17-24	Downgrade	Wedbush	Outperform → Neutral
Mar-25-24	Resumed	Jefferies	Buy
Dec-08-23	Initiated	Wells Fargo	Equal Weight
Mar-01-23	Initiated	Guggenheim	Buy
Dec-06-22	Upgrade	BTIG Research	Neutral → Buy
Sep-19-22	Resumed	Wedbush	Outperform
Aug-16-22	Downgrade	BTIG Research	Buy → Neutral
Feb-11-22	Initiated	BTIG Research	Buy
Jul-26-21	Initiated	Cowen	Outperform
Jul-26-21	Initiated	Evercore ISI	Outperform
Jul-26-21	Initiated	Jefferies	Buy
Jul-26-21	Initiated	Wedbush	Outperform

View All

Jade Biosciences Inc Stock (JBIO) Latest News

02:28 AM

How Jade Biosciences Inc. stock reacts to global recession fearsPortfolio Value Report & Short-Term Swing Trade Alerts - ulpravda.ru

02:28 AM

12:05 PM

How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Volume & Weekly Watchlist for Hot Stocks - ulpravda.ru

12:05 PM

09:36 AM

Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru

09:36 AM

Jan 07, 2026

H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com Canada

Jan 07, 2026

This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga

Jan 07, 2026

HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq

Jan 07, 2026

Will Jade Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team semifinals star players counter attacking odds analysis preview - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN

Jan 06, 2026

The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st

Jan 06, 2026

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance

Jan 06, 2026

Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria

Jan 06, 2026

Jan 05, 2026

Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN

Dec 26, 2025

Dec 24, 2025

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat

Dec 24, 2025

Dec 23, 2025

Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 23, 2025

Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Dec 23, 2025

Dec 22, 2025

Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com

Dec 22, 2025

Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat

Dec 22, 2025

What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Dec 22, 2025